Joseph O Johnson

6PUBLICATIONS
59CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 11, 2026
KRAS-G12C inhibition-induced enrichment of MHC-Ihigh immune-active tumor cells directs immune-effector TME development to augment therapeutic efficacy.

|May 01, 2025
Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida.

Abigail E Lantz, Edna R Gordián, Marilin Rosa

|Apr 29, 2025
Eco-Evolutionary Guided Pathomic Analysis Detects Biomarkers to Predict Ductal Carcinoma In Situ Upstaging.

Yujie Xiao, Manal Elmasry, Ji Dong K Bai

|Jan 21, 2025
In Situ RAS:RAF Binding Correlates with Response to KRASG12C Inhibitors in KRASG12C-Mutant Non-Small Cell Lung Cancer.

Ryoji Kato, Hitendra S Solanki, Hilal Ozakinci

|Feb 09, 2023
Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity.

Hong Zheng, Xiaoqing Yu, Mohammed L Ibrahim

|Dec 08, 2022
Elevated Methionine Flux Drives Pyroptosis Evasion in Persister Cancer Cells.

Asmaa El-Kenawi, Anders Berglund, Veronica Estrella

Pageof 1

Frequent Collaborators

3 joint publications

Theresa A Boyle

2 joint publications

Xiaoqing Yu

2 joint publications

Mengyu Xie

2 joint publications

Mohammed L Ibrahim